CAR-T Therapy Offers New Hope for Multiple Myeloma Patients
Researchers at the Icahn School of Medicine at Mount Sinai have made a groundbreaking discovery in treating multiple myeloma, a blood cancer that often relapses or becomes resistant to initial treatments. A new study found that one-third of patients with relapsed or refractory multiple myeloma remained in remission for at least five years after receiving … Read more